|
1
|
McPherson K, Steel CM and Dixon JM: ABC of
breast diseases. Breast cancer-epidemiology, risk factors, and
genetics. BMJ. 321:624–628. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Benson JR and Jatoi I: The global breast
cancer burden. Future Oncol. 8:697–702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anderson WF, Katki HA and Rosenberg PS:
Incidence of breast cancer in the United States: Current and future
trends. J Natl Cancer Inst. 103:1397–1402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kieffer BL, Befort K, Gaveriaux-Ruff C and
Hirth CG: The delta-opioid receptor: Isolation of a cDNA by
expression cloning and pharmacological characterization. Proc Natl
Acad Sci USA. 89:12048–12052. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Evans CJ, Keith DE Jr, Morrison H,
Magendzo K and Edwards RH: Cloning of a delta opioid receptor by
functional expression. Science. 258:1952–1955. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bzdega T, Chin H, Kim H, Jung HH, Kozak CA
and Klee WA: Regional expression and chromosomal localization of
the delta opiate receptor gene. Proc Natl Acad Sci USA.
90:9305–9309. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simonin F, Befort K, Gavériaux-Ruff C,
Matthes H, Nappey V, Lannes B, Micheletti G and Kieffer B: The
human delta-opioid receptor: Genomic organization, cDNA cloning,
functional expression, and distribution in human brain. Mol
Pharmacol. 46:1015–1021. 1994.PubMed/NCBI
|
|
8
|
Howells RD, Kilpatrick DL, Bailey LC, Noe
M and Udenfriend S: Proenkephalin mRNA in rat heart. Proc Natl Acad
Sci USA. 83:1960–1963. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fickel J, Bagnol D, Watson SJ and Akil H:
Opioid receptor expression in the rat gastrointestinal tract: A
quantitative study with comparison to the brain. Brain Res Mol
Brain Res. 46:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Neidle A, Manigault I and Wajda IJ:
Distribution of opiate-like substances in rat tissues. Neurochem
Res. 4:399–410. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wittert G, Hope P and Pyle D: Tissue
distribution of opioid receptor gene expression in the rat. Biochem
Biophys Res Commun. 218:877–881. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Radulović J and Janković BD: Opposing
activities of brain opioid receptors in the regulation of humoral
and cell-mediated immune responses in the rat. Brain Res.
661:189–195. 1994. View Article : Google Scholar
|
|
13
|
Kilpatrick DL, Howells RD, Noe M, Bailey
LC and Udenfriend S: Expression of preproenkephalin-like mRNA and
its peptide products in mammalian testis and ovary. Proc Natl Acad
Sci USA. 82:7467–7469. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CL, Chang CC, Krieger DT and Bardin
CW: Expression and regulation of proopiomelanocortin-like gene in
the ovary and placenta: Comparison with the testis. Endocrinology.
118:2382–2389. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Civelli O, Douglass J, Goldstein A and
Herbert E: Sequence and expression of the rat prodynorphin gene.
Proc Natl Acad Sci USA. 82:4291–4295. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Debruyne D, Leroy A, DE Wever O, Vakaet L,
Mareel M and Bracke M: Direct effects of delta opioid receptor
agonists on invasion-associated activities of HCT-8/E11 colon
cancer cells. Anticancer Res. 30:9–17. 2010.PubMed/NCBI
|
|
17
|
Kuniyasu H, Luo Y, Fujii K, Sasahira T,
Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y and Ohmori H: CD10
enhances metastasis of colorectal cancer by abrogating the
anti-tumoural effect of methionine-enkephalin in the liver. Gut.
59:348–356. 2010. View Article : Google Scholar
|
|
18
|
Schreiber G, Campa MJ, Prabhakar S,
O'Briant K, Bepler G and Patz EF Jr: Molecular characterization of
the human delta opioid receptor in lung cancer. Anticancer Res.
18:1787–1792. 1998.PubMed/NCBI
|
|
19
|
Cieślińska A, Sienkiewicz-Szłapka E,
Kostyra E, Fiedorowicz E, Snarska J, Wroński K, Tenderenda M,
Jarmołowska B and Matysiewicz M: µ-Opioid receptor gene (OPRM1)
polymorphism in patients with breast cancer. Tumour Biol.
36:4655–4660. 2015. View Article : Google Scholar
|
|
20
|
Molè D, Gentilin E, Gagliano T, Tagliati
F, Bondanelli M, Pelizzo MR, Rossi M, Filieri C, Pansini G, degli
Uberti EC, et al: Protein kinase C: A putative new target for the
control of human medullary thyroid carcinoma cell proliferation in
vitro. Endocrinology. 153:2088–2098. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wickley PJ, Ding X, Murray PA and Damron
DS: Propofol-induced activation of protein kinase C isoforms in
adult rat ventricular myocytes. Anesthesiology. 104:970–977. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saberi B, Shinohara M, Ybanez MD, Hanawa
N, Gaarde WA, Kaplowitz N and Han D: Regulation of H(2)O(2)-induced
necrosis by PKC and AMP-activated kinase signaling in primary
cultured hepatocytes. Am J Physiol Cell Physiol. 295:C50–C63. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ali AS, Ali S, El-Rayes BF, Philip PA and
Sarkar FH: Exploitation of protein kinase C: A useful target for
cancer therapy. Cancer Treat Rev. 35:1–8. 2009. View Article : Google Scholar
|
|
24
|
Oskoueian E, Abdullah N and Ahmad S:
Phorbol esters from Jatropha meal triggered apoptosis, activated
PKC-δ, caspase-3 proteins and down-regulated the proto-oncogenes in
MCF-7 and HeLa cancer cell lines. Molecules. 17:10816–10830. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Z, Wang N, Fang J, Huang J, Tian F, Li
C and Xie F: Role of PKC-ERK signaling in tamoxifen-induced
apoptosis and tamoxifen resistance in human breast cancer cells.
Oncol Rep. 27:1879–1886. 2012.PubMed/NCBI
|
|
26
|
Zhu M, Li M, Yang F, Ou X, Ren Q, Gao H,
Zhu C and Guo J: Mitochondrial ERK plays a key role in δ-opioid
receptor neuroprotection against acute mitochondrial dysfunction.
Neurochem Int. 59:739–748. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sancho P, Galeano E, Estañ MC, Gañán-Gómez
I, Boyano-Adánez MC and García-Pérez AI: Raf/MEK/ERK signaling
inhibition enhances the ability of dequalinium to induce apoptosis
in the human leukemic cell line K562. Exp Biol Med (Maywood).
237:933–942. 2012. View Article : Google Scholar
|
|
28
|
Zhao M, Wang HX, Yang J, Su YH, Su RJ and
Wong TM: delta-Opioid receptor stimulation enhances the growth of
neonatal rat ventricular myocytes via the extracellular
signal-regulated kinase pathway. Clin Exp Pharmacol Physiol.
35:97–102. 2008. View Article : Google Scholar
|
|
29
|
Hayashi T, Tsao LI and Su TP:
Antiapoptotic and cytotoxic properties of delta opioid peptide
[D-Ala(2),D-Leu(5)] enkephalin in PC12 cells. Synapse. 43:86–94.
2002. View Article : Google Scholar
|
|
30
|
Bilecki W, Zapart G, Ligeza A,
Wawrzczak-Bargiela A, Urbański MJ and Przewłocki R: Regulation of
the extracellular signal-regulated kinases following acute and
chronic opioid treatment. Cell Mol Life Sci. 62:2369–2375. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
American Cancer Society: Cancer facts and
figures. 2006, http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf
Accessed February 7, 2007.
|
|
32
|
Kuhl CK, Schrading S, Leutner CC,
Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W and Schild HH:
Mammography, breast ultrasound, and magnetic resonance imaging for
surveillance of women at high familial risk for breast cancer. J
Clin Oncol. 23:8469–8476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brownstein MJ: A brief history of opiates,
opioid peptides, and opioid receptors. Proc Natl Acad Sci USA.
90:5391–5393. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Al-Hasani R and Bruchas MR: Molecular
mechanisms of opioid receptor-dependent signaling and behavior.
Anesthesiology. 115:1363–1381. 2011.PubMed/NCBI
|
|
35
|
Su TP: Delta opioid peptide[D-
Ala(2),D-Leu(5)]enkephalin promotes cell survival. J Biomed Sci.
7:195–199. 2000.PubMed/NCBI
|
|
36
|
Kim H, Lee SW, Park JS, Min JH and Kim HK:
Genomic analysis of [d-Ala2, d-Leu5]
enkephalin preconditioning in cortical neuron and glial cell injury
after oxygen deprivation. Brain Res. 1447:91–105. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Avella DM, Kimchi ET, Donahue RN, Tagaram
HR, McLaughlin PJ, Zagon IS and Staveley-O'Carroll KF: The opioid
growth factor-opioid growth factor receptor axis regulates cell
proliferation of human hepatocellular cancer. Am J Physiol Regul
Integr Comp Physiol. 298:R459–R466. 2010. View Article : Google Scholar :
|
|
38
|
Stewart ZA, Westfall MD and Pietenpol JA:
Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol
Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Allen TR, Krueger KD, Hunter WJ III and
Agrawal DK: Evidence that insulin-like growth factor-1 requires
protein kinase C-epsilon, PI3-kinase and mitogen-activated protein
kinase pathways to protect human vascular smooth muscle cells from
apoptosis. Immunol Cell Biol. 83:651–667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Agudo-López A, Miguel BG, Fernández I and
Martínez AM: Role of protein kinase C and mitochondrial
permeability transition pore in the neuroprotective effect of
ceramide in ischemia-induced cell death. FEBS Lett. 585:99–103.
2011. View Article : Google Scholar
|
|
41
|
Peng Y, Hu Y, Feng N, Wang L and Wang X:
L-3-n-butyl-phthalide alleviates hydrogen peroxide-induced
apoptosis by PKC pathway in human neuroblastoma SK-N-SH cells.
Naunyn Schmiedebergs Arch Pharmacol. 383:91–99. 2011. View Article : Google Scholar
|
|
42
|
Heiss A, Ammer H and Eisinger DA:
delta-Opioid receptor-stimulated Akt signaling in neuroblastoma ×
glioma (NG108-15) hybrid cells involves receptor tyrosine
kinase-mediated PI3K activation. Exp Cell Res. 315:2115–2125. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang D, Ding Y, Luo WM, Bender S, Qian
CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, et al:
Inhibition of MAPK kinase signaling pathways suppressed renal cell
carcinoma growth and angiogenesis in vivo. Cancer Res. 68:81–88.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tang B, Du J, Gao ZM, Liang R, Sun DG, Jin
XL and Wang LM: DADLE suppresses the proliferation of human liver
cancer HepG2 cells by activation of PKC pathway and elevates the
sensitivity to cis-diammine dichloridoplatium. Zhonghua Zhong Liu
Za Zhi. 34:425–429. 2012.In Chinese. PubMed/NCBI
|
